Cara Therapeutics Inc (NASDAQ:CARA)

13.22
Delayed Data
As of Oct 28
 -0.54 / -3.92%
Today’s Change
8.88
Today|||52-Week Range
26.67
-17.94%
Year-to-Date

Today’s Trading

Previous close13.76
Today’s open13.50
Day’s range13.02 - 13.50
Volume12,956
Average volume (3 months)401,227
Market cap$668.6M
Data as of 3:58pm ET, 10/28/2020

Growth & Valuation

Earnings growth (last year)-20.90%
Earnings growth (this year)+5.42%
Earnings growth (next 5 years)-66.83%
Revenue growth (last year)+47.64%
P/E ratioNM
Price/Sales34.57
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.36-2.61%
BCRXBioCryst Pharmaceuti...-0.08-2.02%
KDMNKadmon Holdings Inc-0.13-3.59%
VXRTVaxart Inc-0.44-8.09%
Data as of 3:59pm ET, 10/28/2020

Financials

Last reporting dateOctober 29, 2020
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$19.9M
Annual profit (last year)-$106.4M
Net profit margin-534.91%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Stamford, Connecticut

Forecasts